FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


SWK Holdings Provides $25MM Loan Facility to Aziyo Biologics

August 11, 2022, 07:09 AM
Filed Under: Medical
Related: SWK Holdings

Aziyo Biologics, a commercial-stage regenerative medicine company entered into a $25 million credit facility from SWK Holdings Corporation.

The new credit facility provides for an initial term loan of $21 million that the Company intends to use to fund its ongoing commercial and product development initiatives, refinance its existing debt facilities, and to pay off all such other outstanding debt. In addition, the Company also has the option to draw under the new credit facility an additional term loan of $4 million, subject to the achievement of specified operational and financial metrics by September 30, 2023. The loan facility allows for the establishment of a new asset-based revolving loan facility of up to $8 million.

“We are delighted to establish a relationship with SWK. This new capital helps strengthen our balance sheet and provide Aziyo with substantially greater financial flexibility,” said Dr. Randy Mills, Aziyo’s Chief Executive Officer. “Moreover, the added liquidity will allow Aziyo to advance our existing product portfolio and develop additional innovative products that leverage our platform of regenerative technologies to serve unmet medical needs.”

“We’ve built a strong conviction in the strength of Aziyo’s product portfolio and its prospects for sustained growth and value creation,” commented Winston Black, CEO of SWK Holdings. “I’m excited that SWK is able to provide significant capital infusion to support Aziyo’s mission of advancing regenerative medicine platforms to dramatically improve patient outcomes.”

Week's News

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.